Clinical and Experimental Metastasis

Clinical and Experimental Metastasis (official journal of the MRS)

Clinical & Experimental Metastasis is an international, multidisciplinary journal devoted to the rapid publication of fundamental advances in basic and applied metastasis research. The coverage encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It includes such areas as molecular biology, pharmacology, tumour biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the journal's core subject of metastasis formation, prevention and treatment. Link

Submit online.

Editors:CEM

Robin Anderson

Principal Research Fellow Head
Metastasis Research Laboratory
Peter MacCallum Cancer Centre, Australia
Email: robin.anderson@petermac.org

Suzanne A. Eccles

Tumour Biology and Metastasis
Cancer Research UK Centre for Cancer Therapeutics
McElwain Laboratories, Institute of Cancer Research, Sutton, UK
Email: Sue.Eccles@icr.ac.uk

Tatsuro Irimura

Laboratory of Cancer Biology & Molecular Immunology
University of Tokyo, Japan
Email: irimura@mol.f.u-tokyo.ac.jp 

Editor Emeritus

Josh Fidler

University of Texas MD Anderson Cancer Center
Houston, USA 

Kurt Hellmann (1922-2013)

United Kingdom
In Memoriam

Garth Nicolson

Institute for Molecular Medicine
Laguna Beach, USA  

 

Editorial Board:

A. Albini, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; 
A.F. Chambers, London Regional Cancer Center, London, Canada
A.-L. Cheng, National Taiwan University Hospital, Taipei, Taiwan
D. Edwards, University of East Anglia, Norwich, UK
W.-G. Fang, University Health Science Center, Beijing, China
Ø. Fodstad, Norwegian Radium Hospital, Oslo, Norway
P. Friedl, University of Wurzburg, Wurzburg, Germany
R. Giavazzi, Mario Negri Institute, Bergamo, Italy
J. Haier, University Hospital Muenster, Muenster, Germany
I. Holen, The Medical School, Sheffield, UK
K. Hunter, National Institutes of Health, Bethesa, USA
N.E. Hynes, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
K. Itoh, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
E.C. Kohn, National Institutes of Health, Bethesda, MD, USA
C. López-Otín, Universidad de Oviedo, Oviedo, Spain
C.C. Lynch, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA
A. Mastro, Pennsylvania State University, University Park, USA
K. Pantel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
L.-X. Qin, Fudan University, Shanghai, China
C. Rinker-Schaeffer, The Cancer Research Center, Chicago, USA
I. Saiki, University of Toyama, Toyama, Japan
R. Samant, University of Alabama at Birmingham, Birmingham, USA
M. Seiki, Institute of Medical Science, Tokyo, Japan
A. Sierra,  L'Hospitalet de Llobregat, Barcelona, Spain
J. Sleeman, University of Heidelberg, Mannheim, Germany
P.S. Steeg, National Cancer Institute, Bethesa, USA
S. Sone, Tokushima University, Nankoku City, Japan
J. Talmadge, University of Nebraska Medical Center, Omaha, USA
J.-P. Thierry, National University of Singapore, Singapore
E. Thompson, St. Vincent's Institute of Medical Research, Melbourne, Australia
J. Timár, Semmelweiss Medical University, Budapest, Hungary
D. R. Welch, Kansas University Cancer Center, USA
D. Yu, The Univ. Texas MD Anderson Cancer Center, Houston, USA

 

Would you like to be added to our list of potential reviewers? Email Danny Welch at dwelch@kumc.edu with the subject line "Reviewer CEM".